<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - ADMA Biologics Inc</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Mon, 20 Apr 2026 20:08:05 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>ADMA 2,29$ (-46%)</title>
<link>http://www.aktiencheck.de/forum/ADMA_2_29_46-A12FAG-t560230</link>
<guid>http://www.aktiencheck.de/forum/ADMA_2_29_46-A12FAG-t560230</guid>
<description>Fundamental, https://de.marketscreener.com/kurs/aktie/ADMA-BIOLOGICS-INC-18474966/


https://www.finanzen.net/schaetzungen/adma_biologics

https://finviz.com/quote.ashx?t=ADMA&amp;p=d

https://stocktwits.com/news-articles/markets/equity/adma-stock-retail-traders-see-upside-after-q4-2024-earnings/chejEKORCT

The specialty plasma-derived biologics manufacturer reported fourth-quarter (Q4) earnings per share (EPS) of $0.46, crushing consensus estimates of $0.15.

Revenue surged to $117.55 million, surpassing Wall Street's forecast of $112.8 million. [&lt;a href=&#034;http://www.aktiencheck.de/forum/ADMA_2_29_46-A12FAG-t560230&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







